In a groundbreaking discovery, Indian scientists have found that the drug SB431542, originally developed for cancer research, shows significant promise in combating COVID-19. The study, initially released as a preprint on bioRxiv and later accepted for publication in the Journal of Virology, highlights the potential of this drug to become a vital tool in the fight against the global pandemic. With over 30 anti-COVID vaccines approved by the World Health Organization, experts emphasize the need for additional treatments as the virus continues to evolve and existing options may lose efficacy. SB431542, known for its role in blocking TGF-β signaling, has demonstrated unique capabilities in inhibiting the coronavirus through multiple mechanisms. By targeting key pathways involved in viral entry, assembly, and cell survival, this drug presents a novel approach that distinguishes it from current antiviral medications. Notably, SB431542’s effectiveness extends to other coronaviruses like IBV, showcasing its broad spectrum of activity. What sets this drug apart is its ability to prevent the development of drug-resistant variants, a significant advantage over existing treatments. The collaborative efforts of Indian research institutions have led to this groundbreaking discovery, offering hope for a promising solution to the ongoing global health crisis.
Read more from theprint.in